Synthpop.
The AI Fixing Healthcare's Back Office

American healthcare does not lack for doctors so much as it drowns in process. A single prior authorization - the permission slip an insurer demands before a patient gets equipment, a test or a drug - can consume 40 minutes of a coordinator's day, most of it spent on hold, retyping records or chasing missing signatures. Synthpop, a Cambridge, Massachusetts company founded in 2023, was built to make that work disappear.

The company builds what it calls an agentic AI automation platform: a coordinated system of software agents that reads clinical documents, reasons about insurance rules, and even makes phone calls, all to move a patient's paperwork from referral to reimbursement without a human doing the grunt work. Synthpop says the system can automate up to 80% of the business processes it targets, turning that 40-minute task into one that finishes in under a minute at roughly five times lower cost than paying people to do it.

It is an unglamorous problem, which is precisely the point. While much of healthcare AI chases diagnosis and imaging, Synthpop went after the back office - the eligibility checks, claims follow-ups and referral queues where money and morale quietly leak out. In February 2026 the bet drew a $15 million Series A led by Ansa Capital, lifting total funding to $23 million and putting a former Humana chief executive on the cap table.

Synthpop's founders like to frame the market with a simple observation: most vendors are either AI companies learning healthcare or healthcare companies experimenting with AI. Synthpop set out to be both from inception - pairing deep healthcare product expertise with frontier multi-agent engineering.

That engineering got a notable boost when Synthpop added the team behind airt, led by Davor Runje and Hajdi Cenan, who contributed to Microsoft's AutoGen framework - one of the systems that helped popularize multi-agent AI. Rather than shipping a single chatbot or a narrow point tool, Synthpop coordinates several specialized agents that hand work to one another, which is what lets it chase entire workflows instead of isolated steps.

Business model. Synthpop is a B2B SaaS company. It sells its agentic platform to healthcare providers and organizations as a replacement for manual administrative labor, priced against the volume of workflows it automates and pitched on a stated 5x cost advantage over human staff - all delivered as a HIPAA-compliant, SOC 2-certified system.

Where it fits. Synthpop operates in the crowded lane of healthcare administrative and revenue-cycle automation, where it competes with players like Notable and ABI Health and brushes up against incumbents such as athenahealth. Its wedge has been to go vertical-first - starting with niche provider types like DME suppliers, diagnostic labs and sleep-medicine practices - rather than trying to boil the ocean of healthcare all at once.